🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT06570083
Active, not recruiting Not applicable

Mobile-Based Intervention to Promote Physical Activity Among the Elderly

NCT06570083 · tracked via the Priya Life Science China tracker
Sponsor
Beijing Normal University
Phase
Not applicable
Started
2025-09-01
Last updated
2026-09-02

Condition(s) studied

Mobile HealthPhysical Activity

Investigational drug(s) / intervention(s)

Mobile Exercise SupportSelf-help physical activity booklet

Mobile Exercise Support: Participants receive three months of personalized support via WeChat, including tailored exercise recommendations, motivational messages, and educational content.

Self-help physical activity booklet: Participants receive a self-help booklet to promote physical activity among the elderly. The booklet will include guidelines for safe and effective exercises, tips for staying motivated, and information on the health benefits of regular physical activity.

Study summary

This study aims to explore the feasibility and preliminary effectiveness of a mobile phone-based intervention among elderly individuals with chronic diseases.

Eligibility

Sex
ALL
Min age
60 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. Age ≥60 years and diagnosed with at least one chronic disease 2. Owns a smartphone and is proficient in using WeChat 3. Daily sedentary time ≥6 hours Exclusion Criteria: 1. recent surgeries, injuries, or other conditions that would prevent simple physical activity 2. hearing, vision, or physical disabilities

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Beijing Normal University Zhuhai Guangdong

More Beijing Normal University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06570083 on ClinicalTrials.gov ↗ ← All trials in China